Constellation Alpha

Alpha Healthcare Acquisition Corp.

  • Alpha Healthcare Acquisition Corp. is a special purpose acquisition company (SPAC) formed by Constellation Alpha Holdings
  • The Company raised $100 million via an initial public offering and began trading on the Nasdaq under the ticker symbol AHACU on September 18, 2020
  • Previous SPAC acquired DermTech (ticker: DMTK), an innovative molecular diagnostics company with a non-invasive diagnostics test for skin cancer
  • As of our IPO, DMTK was among the top 3 healthcare SPAC deals by gain over transaction price
  • DMTK was inducted to the Russell 2000 in June 2020

Team

  • Rajiv Shukla, Chairman & CEO. 3-time public company CEO. Private Equity investor at Citi and MD/PM of healthcare hedge fund at Morgan Stanley, led M&A for Pfizer Global R&D
  • Patrick Sturgeon, CFO. MD/M&A head at Brookline Capital, MD at Axiom Capital, VP at Freeman
  • Bruce Springer, Board Director. Chairman & CEO of ProlucentHealth. 4-time healthtech CEO. Former COO of WebMD. Healthcare advisor to Francisco Partners for 13 years
  • Brian Robertson, Board Director. Founder & CEO of VisiQuate. 3-time founder of healthtech companies
  • Terry Carlson, Board Director. Former General Counsel for 3 medical device companies (Synthes, Medtronic, PerkinElmer)
  • Kevin Xie, Board Director. CFO of Gracell Biotech. Former Portfolio Manager of 3 healthcare hedge funds (Great Point, Scopia, Locust Walk)

Target Screening Criteria

  • Geography: USA
  • Sector: Digital Healthcare, HCIT, Medical Devices, Therapeutics and Healthcare Services
  • Valuation range: $0.5 to 3.0 billion

Must-Have Target Features

  • Highly respected management team and board of directors
  • Institutionally validated through investment by top-tier Venture or Private Equity firm(s)
  • Among the leaders in business category – should have proven track record of success
  • Sectoral Themes:
    • Drive outpatient care: home healthcare (including digital health), self-care devices and online services, non-invasive diagnostics
    • Improve efficiency: Healthcare IT & Analytics, Revenue Cycle Management, Care & Case management, Industry consolidation to drive scale synergies (dental, derma, hospice)
    • Address significant unmet need: Oncology, CNS (Alzheimer’s, Parkinson’s), Pain, Behavioral Health, AMD, Orphan Diseases, Orthopedics, etc.